Related Experiment Video

Updated: Aug 23, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.9K

Three shades of black - secondary thrombotic microangiopathy

Rhituparna Das1, Saugat Dasgupta2, Moumita Sengupta1

  • 1Department of Pathology, IPGME&R and SSKM Hospital, Kolkata, West Bengal, India.

Indian Journal of Pathology & Microbiology
|October 29, 2022
PubMed

Insights

Thrombotic microangiopathy (TMA) involves anemia, low platelets, and organ damage. Understanding TMA pathogenesis is crucial due to varied presentations and distinct renal impacts in primary versus secondary forms.

Area of Science:

  • Hematology
  • Nephrology
  • Pathology

Background:

  • Thrombotic microangiopathy (TMA) is a serious condition.
  • It presents with hemolytic anemia, thrombocytopenia, and organ damage.
  • TMA has a wide age distribution and varied clinical presentations.

Purpose of the Study:

  • To deepen the understanding of thrombotic microangiopathy pathogenesis.
  • To differentiate primary TMA from secondary causes.
  • To highlight the distinct renal damage patterns in different TMA types.

Main Methods:

  • Review of clinical presentations and diagnostic markers for TMA.
  • Analysis of schistocytes in peripheral smears as an early indicator.
  • Examination of arteriolar thrombi via light microscopy.

Main Results:

  • Primary TMA can be occult until triggered by external factors.
  • Secondary TMA requires identification of the underlying cause for effective treatment.
  • Schistocytes and arteriolar thrombi are key diagnostic signs.

Conclusions:

  • A comprehensive understanding of TMA pathogenesis is needed.
  • Distinguishing primary from secondary TMA is clinically significant.
  • Prompt diagnosis and identification of underlying causes are vital for managing TMA and its renal complications.
Keywords:
Light microscopysecondarythrombotic Microangiopathy

More Related Videos

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

10.1K
Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

18.4K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
26
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
849
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
27
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.1K